BioNanomatrix Founder and CSO Dr. Han Cao Awarded Chinese Rising Star Entrepreneur Award

PHILADELPHIA, Oct. 7 /PRNewswire/ -- BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, announced today that Founder and Chief Scientific Officer, Han Cao, Ph.D., was awarded the Chinese Rising Star Entrepreneur Award at the China International Economic and Technical Cooperation Forum in Beijing, China on September 27, 2010.  The award is in recognition of Dr. Cao's entrepreneurial spirit and success in the founding of BioNanomatrix and the development of the Company's novel genomic analysis technology.  

Commenting on the milestone, Edward L. Erickson BioNanomatrix's president and chief executive officer, said: "This is a very great honor for Han and for the company he founded, BioNanomatrix.  We believe that the largest country markets for our products are the USA and China, with China rapidly becoming a world leader in genomics and life science research generally.  We look forward to mutually beneficial collaboration with Chinese research institutions and scientists as we commercialize our revolutionary technology."

About BioNanomatrix

BioNanomatrix, Inc., a privately held genomics company, is developing and commercializing game-changing, proprietary technologies for analysis of large biological molecules, such as nucleic acids that are extremely important in life science research, clinical diagnostic applications, and development of new therapeutics.  This technology is designed to reduce dramatically the time and complexity to analyze the genome.  BioNanomatrix's products will provide users with the means to perform single-molecule analyses on minute biological samples that are essentially impossible, impractical or too expensive with current technology.  For more information, visit: www.bionanomatrix.com.

Note: NANOANALYZER is a registered trademark of BioNanomatrix, Inc. The names of other companies, other entities, products and/or services mentioned herein may be the trademarks of their respective owners.

SOURCE BioNanomatrix, Inc.